The Effect of Dehydroepiandrosterone on Ovarian Reserve in Ovarian Damage Caused by Methotrexate

Authors

DOI:

https://doi.org/10.31964/mltj.v6i1.270

Keywords:

dehydroepiandrosterone, methotrexate, AMH, ovary, reserve

Abstract

To determine the possible detrimental effects of multiple methotrexate doses has on the ovarian reserve and to determine the beneficial effects of dehydroepiandrosterone supplementation. The rats (n:24) divided into three groups; Group 1: control group, Group 2: dehydroepiandrosterone and methotrexate group (6mg/kg dehydroepiandrosterone dissolved in 0.1 ml sesame seed oil subcutaneously for ten days and 1mg/kg intramuscular methotrexate at the 1st, 3rd, 5th and 7th days) and Group 3: methotrexate group (1mg/kg intramuscular methotrexate at the 1st, 3rd, 5th and 7th day). The groups compared in regards to their histopathological ovarian damage scores and AMH values. It established that multiple methotrexate applications had a considerable effect on reducing vascular congestion in the ovarian tissue. Both in groups 2 and 3 AMH values found to be significantly lower. When this decline in the ovarian reserve examined comparatively; while both the group 2 and 3 reported having a considerable and continuous reduction in the AMH levels correlative to the control group; the primordial, primary and total follicle counts shown to stay statistically the same in the group 2 (p<0.0167). The dehydroepiandrosterone supplementation, while did not have a significant effect on reducing ovarian damage induced by methotrexate, also was not shown to provide any considerable increase in AMH levels. However, prolonged usage of dehydroepiandrosterone by contributing to the antral follicle pool considered promising in increasing the AMH levels conceivably

Author Biographies

Ali Doğukan Anğın, University of Health Sciences,

Dr Lütfi Kırdar Kartal Training and Research Hospital, Department of Obstetrics and Gynecology,

Ebru Çöğendez, University of Health Sciences,

Zeynep Kamil Women's and Children's Disease Training and Research Hospital, Department of Obstetrics and Gynecology

İsmet Gün, University of Health Sciences,

Sultan Abdülhamid Han Training and Research Hospital, Department of Obstetrics and Gynecology

Önder Sakin, University of Health Sciences,

Dr Lütfi Kırdar Kartal Training and Research Hospital, Department of Obstetrics and Gynecology

Muzaffer Seyhan Çıkman, University of Health Sciences,

Dr Lütfi Kırdar Kartal Training and Research Hospital, Department of Obstetrics and Gynecology,

Kayhan Başak, University of Health Sciences,

Dr Lütfi Kırdar Kartal Training and Research Hospital, Department of Pathology,

Asuman Orçun Kaptanağası, University of Health Sciences,

Dr Lütfi Kırdar Kartal Training and Research Hospital, Department of Biochemistry

Yasemin Alan, İzmir Metropolitan Municipality Eşrefpaşa Hospital

Department of Obstetrics and Gynecology

Murat Alan, University of Health Sciences

Tepecik Education and Research Hospital, Department of Obstetrics and Gynecology

Emrah Beyan, University of Health Sciences

Tepecik Education and Research Hospital, Department of Obstetrics and Gynecology

Downloads

Published

2020-05-22

How to Cite

Anğın, A. D., Çöğendez, E., Gün, İsmet, Sakin, Önder, Çıkman, M. S., Başak, K., Orçun Kaptanağası, A., Alan, Y., Alan, M., & Beyan, E. (2020). The Effect of Dehydroepiandrosterone on Ovarian Reserve in Ovarian Damage Caused by Methotrexate. Medical Laboratory Technology Journal, 6(1). https://doi.org/10.31964/mltj.v6i1.270

Issue

Section

Articles